Resmed Inc (RMD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 06/30
| 12-2020 | 09-2020 | 06-2020 | 03-2020 | 12-2019 | |
| Sales | 800,011 | 751,944 | 770,345 | 769,455 | 736,157 |
| Cost of Goods | 337,528 | 313,283 | 320,970 | 319,793 | 309,027 |
| Gross Profit | 462,483 | 438,661 | 449,375 | 449,662 | 427,130 |
| Operating Expenses | 241,295 | 222,048 | 227,097 | 232,955 | 229,348 |
| Operating Income | 221,716 | 216,896 | 223,248 | 217,500 | 197,809 |
| Interest Expense | 5,792 | 6,725 | 8,176 | 9,968 | 10,220 |
| Other Income | -5,332 | 5,683 | -2,978 | -15,877 | -8,837 |
| Pre-tax Income | 210,592 | 215,854 | 212,094 | 191,655 | 178,752 |
| Income Tax | 31,078 | 37,482 | 34,259 | 28,518 | 18,198 |
| Net Income Continuous | 179,514 | 178,372 | 177,835 | 163,137 | 160,554 |
| Net Income | $179,514 | $178,372 | $177,835 | $163,137 | $160,554 |
| EPS Basic Total Ops | 1.24 | 1.23 | 1.23 | 1.13 | 1.11 |
| EPS Basic Continuous Ops | 1.24 | 1.23 | 1.23 | 1.13 | 1.11 |
| EPS Diluted Total Ops | 1.23 | 1.22 | 1.22 | 1.12 | 1.10 |
| EPS Diluted Continuous Ops | 1.23 | 1.22 | 1.22 | 1.12 | 1.10 |
| EBITDA(a) | $269,785 | $266,784 | $268,756 | $263,965 | $243,292 |